D. Kühnhardt

A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines.

R. Greil, H. van de Velde, S. Kümmel, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Influence of Chemotherapy on the Antioxidant Status of Human Skin.

Sora Jung, Jürgen Lademann, Alexa Patzelt, 2016, Anticancer research.

Increased proteasome activator 28 gamma (PA28γ) levels are unspecific but correlate with disease activity in rheumatoid arthritis

D. Kühnhardt, S. Rödiger, E. Feist, 2014, BMC Musculoskeletal Disorders.

Contrast-Enhancing Meningeal Lesions Are Associated with Longer Survival in Breast Cancer-Related Leptomeningeal Metastasis

K. Possinger, D. Kühnhardt, S. Lehenbauer-Dehm, 2008, Breast Care.

PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial.

R. Greil, H. Eich, V. Diehl, 2021, The Lancet. Haematology.

Phase I study of the novel, fully synthetic epothilone sagopilone (ZK-EPO) in patients with solid tumors.

E. Thiel, K. Possinger, P. Schmid, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group

R. Greil, H. Eich, V. Diehl, 2017, The Lancet.

Serum levels of total-RANKL in multiple myeloma.

O. Sezer, D. Kühnhardt, E. Terpos, 2009, Clinical lymphoma & myeloma.

Association of IL-6, Hypothalamus-Pituitary-Adrenal Axis Function, and Depression in Patients With Cancer

K. Possinger, P. Schmid, D. Kühnhardt, 2010, Integrative cancer therapies.

Plasma IL-6 and HPA-axis function in depression and anxiety in patients with cancer

K. Possinger, D. Kühnhardt, B. Flath, 2005 .